Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

DNA vaccines.

T H Scott-Taylor1, A G Dalgleish

  • 1Department of Oncology, St George's Hospital Medical School, London, SW17 0RE, UK.

Expert Opinion on Investigational Drugs
|November 4, 2000
PubMed
Summary
This summary is machine-generated.

DNA vaccines offer a simple, versatile, and economical approach to stimulating the immune system by directly inoculating muscle tissues with DNA coding for antigens. Despite challenges, DNA vaccine research is rapidly advancing for infectious diseases and cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of Gemcitabine based chemotherapy on the immunogenicity of pancreatic tumour cells and T-cells.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2020
Same author

Gemcitabine alters the proteasome composition and immunopeptidome of tumour cells.

Oncoimmunology·2018
Same author

The T4 molecule: function and structure.

Immunology today·2014
Same author

B cells in the pathogenesis of AIDS.

Immunology today·2014
Same author

Treatment patterns, outcomes, and resource utilization of patients with metastatic melanoma in the U.K.: the MELODY study.

The British journal of dermatology·2013
Same author

Supernatants derived from chemotherapy-treated cancer cell lines can modify angiogenesis.

British journal of cancer·2012
Same journal

Investigational new drug TAP-1502 beginning clinical study for seborrheic dermatitis.

Expert opinion on investigational drugs·2026
Same journal

Cannabinoid use in adults with sickle cell disease: therapeutic development and clinical insights.

Expert opinion on investigational drugs·2026
Same journal

Odronextamab: a bispecific antibody for follicular lymphoma.

Expert opinion on investigational drugs·2026
Same journal

Evaluating the investigational drug landscape for <i>ESR1</i>-mutated, estrogen receptor-positive, HER2-negative metastatic breast cancer.

Expert opinion on investigational drugs·2026
Same journal

Darigabat and subtype-selective GABA-A modulation: pharmacology, clinical development, and translational challenges.

Expert opinion on investigational drugs·2026
Same journal

Safety, tolerability, and pharmacokinetics of HL-300, a novel topical pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trial.

Expert opinion on investigational drugs·2026
See all related articles

Area of Science:

  • Immunology
  • Molecular Biology
  • Vaccinology

Background:

  • Traditional vaccine methods face challenges with diseases like AIDS and malaria.
  • DNA vaccines present a promising alternative due to their inherent simplicity, versatility, and cost-effectiveness.
  • Significant commercial and academic interest has driven rapid exploration of DNA vaccine technology.

Purpose of the Study:

  • To explore the potential of DNA vaccines for stimulating immune responses.
  • To assess the feasibility of DNA vaccines in addressing global health challenges.
  • To review the current status and future directions of DNA vaccine development.

Main Methods:

  • Direct inoculation of muscle tissues with DNA encoding specific antigens.
  • Utilizing the body's cellular machinery to produce proteins that elicit an immune response.

Related Experiment Videos

  • Ongoing clinical trials investigating efficacy for infectious diseases and cancer.

    • Main Results:

    • DNA vaccines demonstrate potential for stimulating targeted immune responses.
    • The simplicity and economy of DNA vaccine platforms are significant advantages.
    • Clinical trials are underway, indicating progress in translation to human application.

    Conclusions:

    • DNA vaccines represent a highly promising area of vaccine technology.
    • Further research is essential to address and resolve outstanding issues for widespread application.
    • The versatility of DNA vaccines holds potential for diverse therapeutic and prophylactic uses.